Dr. Federica Accornero's lab at Brown University focuses on uncovering the molecular mechanisms that regulate aging and heart function through post-transcriptional modifications of RNA. The lab explores how specific RNA methylation processes, particularly involving the enzyme METTL3, influence gene expression related to aging and cardiac health. By studying these processes, the lab aims to identify potential therapeutic targets for age-related diseases and heart failure.

Dr. Henry N Higgs' lab at Dartmouth College studies the dynamic interplay between the actin cytoskeleton and mitochondria in mammalian cells. The team focuses on understanding how transient actin structures influence mitochondrial function and energy metabolism, particularly in relation to diseases linked to dysfunctional mitochondria. Their research has significant implications for various cellular processes and could lead to insights in treating conditions such as Charcot-Marie-Tooth disease and focal segmental glomerulosclerosis.

Dr. Michael Chapman's lab at the University of Missouri-Columbia focuses on improving gene therapy using adeno-associated viruses (AAV). They study how AAV interacts with host cells to better understand its entry process and develop more efficient gene delivery methods. Their research aims to design safer and more effective AAV vectors that can potentially treat various genetic diseases.

Dr. Rong Li's lab at George Washington University focuses on understanding how adipocytes, a type of fat cell, influence breast cancer and antitumor immunity. The research explores the roles of PD-L1 in the breast tumor microenvironment and seeks to reveal new mechanisms by which T cells respond to the tumor environment, especially in the context of obesity. By investigating these interactions, the lab aims to improve immunotherapy strategies for breast cancer, particularly for patients struggling with obesity-related health challenges.

Dr. Christina Camell's lab at the University of Minnesota studies how aging affects the immune response to infections like sepsis, particularly focusing on adipose tissue, which is a type of fat tissue. They explore how inflammatory changes in this tissue contribute to older individuals being more susceptible to severe infections. Through their research, they aim to identify new ways to improve treatment and outcomes for elderly patients suffering from sepsis.

Dr. Qi Zhang's lab focuses on understanding how aging affects inflammation at the molecular level, particularly involving a protein called cGAS, which plays a crucial role in the immune response. The team investigates how changes in the acetylation of histone proteins can activate cGAS, potentially leading to chronic inflammation and age-related diseases. By bridging molecular biology and biochemistry with aging research, this lab aims to uncover new therapeutic strategies for conditions associated with aging.

Dr. Hao Li's lab at the University of California, San Francisco focuses on understanding and combating the effects of aging through innovative approaches. By utilizing artificial intelligence, the lab aims to identify biomarkers of healthy aging and develop methods for rejuvenating human tissues. Their research includes studying the biological aspects of aging and exploring how certain transcription factors can potentially reverse cellular aging.

Dr. Xaralabos Varelas's lab at Boston University Medical Campus focuses on understanding how aging affects head and neck squamous cell carcinomas (HNSCC) and their associated immune responses. The lab explores how mechanical signals from the extracellular matrix in older tissues influence tumor growth and the tumor microenvironment, aiming to uncover new therapeutic strategies. Ultimately, their work seeks to improve treatment outcomes for patients suffering from HNSCC.

Dr. Emad S Alnemri's lab at Thomas Jefferson University focuses on understanding the NLRP3 inflammasome, a key player in the body's inflammatory response. They investigate how this complex is activated in response to infections and tissue damage, which may lead to various inflammatory diseases such as arthritis and type 2 diabetes. By studying the molecular mechanisms behind NLRP3 activation, they aim to discover new therapeutic approaches to manage these conditions.

Dr. Nicolai Doliba's lab at the University of Pennsylvania focuses on understanding the early cellular changes that occur in the progression of Type 1 Diabetes (T1D). The research particularly investigates how alpha cells, responsible for glucagon secretion, function in individuals at high genetic risk for T1D and how their abnormalities might influence the disease's progression. By examining cell signaling pathways and energy metabolism, the lab aims to uncover potential intervention points to delay or prevent T1D development.

Dr. Jill Kreiling's lab at Brown University is focused on developing non-invasive biomarkers for Alzheimer's disease and related disorders. The team is exploring salivary extracellular vesicles to identify RNA and protein patterns that help predict the risk of developing these neurodegenerative diseases. Their work aims to create accessible testing methods that could lead to earlier interventions for patients before serious symptoms arise.

Dr. Charles G. Glabe's lab at UC Irvine focuses on understanding the formation and dynamics of amyloid plaques, a key feature of Alzheimer's disease. The research aims to investigate how different types of amyloid deposits are formed by various cell types and their roles in the progression of the disease. By using innovative labeling techniques to track proteins in real-time, the lab hopes to uncover new insights that could guide the development of better therapies for Alzheimer's.

Dr. Diane E Merry's lab focuses on understanding spinal and bulbar muscular atrophy (SBMA), a neurodegenerative disease caused by mutations in the androgen receptor. By studying cellular and animal models, the lab aims to uncover the role of protein interactions related to this disease and to develop potential therapeutic strategies. This work seeks to ultimately provide insights into not just SBMA, but also other neurodegenerative conditions associated with protein misfolding.

Dr. Christopher Davies' lab focuses on understanding how the bacteria Neisseria gonorrhoeae becomes resistant to common antibiotics, particularly cephalosporins. By studying the mutations in a protein called PBP2, which plays a vital role in bacterial growth, the lab aims to uncover the molecular mechanisms behind this resistance. Ultimately, this research seeks to inform the development of new antibiotics to combat gonorrhea, a significant public health threat.

Professor Zemer Gitai's lab at Princeton University focuses on developing innovative strategies to tackle antibiotic resistance and enhance our understanding of microbe-host interactions. Using advanced techniques like single-cell RNA sequencing, the lab investigates how bacteria communicate with their hosts and seeks to create novel antibiotics and therapies that can help combat infections while minimizing resistance. This research combines expertise in microbiology, immunology, and computational biology to establish new methods for studying and manipulating bacterial behaviors.

Dr. Nicholas C. Wu's lab focuses on understanding how human antibodies recognize and bind to various antigens, which is essential for developing effective vaccines and therapies. They employ a high-throughput method to study the interactions between antibodies and influenza A virus proteins, aiming to predict antibody epitope specificity based on their amino acid sequences. This research could enhance our knowledge of the human immune system and inform better approaches to fight against pathogens.

Dr. Reuben S. Harris leads a research lab focused on understanding APOBEC enzymes and their role in cancer mutations. His team studies how these enzymes contribute to genetic changes in various cancer types, such as bladder and breast cancer, which can lead to treatment resistance and metastasis. The lab aims to develop new therapies that inhibit these enzymes, ultimately improving cancer treatment outcomes.

Dr. Gregory Bowman's lab at the University of Pennsylvania focuses on understanding the structural role of the apolipoprotein E (ApoE) protein in Alzheimer's disease. By using advanced computer simulations and experimental techniques, the lab aims to uncover the differences between harmful and protective isoforms of ApoE, which could lead to the development of new therapies for Alzheimer's. The research is crucial given the increasing prevalence of Alzheimer's disease as the population ages.

Karim Jean Armache's lab at NYU focuses on understanding how the addition of methyl groups to DNA (a process called DNA methylation) is altered in cancer. Specifically, they study a protein called DNMT3A1 that is important for adding these methyl groups and how its activity is regulated by different chemical modifications on histones, which are proteins that package DNA. By exploring these mechanisms, the lab aims to uncover new strategies for targeting cancer through epigenetic approaches, potentially leading to more effective and less toxic treatments.

Dr. Donald B. Arnold's lab focuses on developing innovative methods to trace and study neural circuits in the brain. Their work aims to understand how neural connections change during development, learning, and disease by using advanced techniques for tracking both excitatory and inhibitory neurons. The research has significant implications for mapping brain function and could aid in addressing various neurological conditions.